CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses
暂无分享，去创建一个
S. Knapp | O. Fedorov | P. Wordsworth | S. Müller | P. Brennan | P. Bowness | F. Martínez | C. Tallant | D. Hay | Christopher Wells | J. D. de Wit | J. Wit | M. Vecellio | A. Hammitzsch | H. Al-Mossawi | A. O’Mahony | M. Al-Mossawi | C. Wells